Literature DB >> 26641134

Efficient and Tumor Targeted siRNA Delivery by Polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate (PEI-PCL-PEG-Fol).

Li Liu1,2, Mengyao Zheng1, Damiano Librizzi3, Thomas Renette1, Olivia M Merkel1,4, Thomas Kissel1.   

Abstract

Efficient delivery of functional nucleic acids into specific cells or tissues is still a challenge for gene therapy and largely depends on targeted delivery strategies. The folate receptor (FR) is known to be overexpressed extracellularly on a variety of human cancers and is therefore an outstanding gate for tumor-targeted Trojan horse-like delivery of therapeutics. In this study, an amphiphilic and biodegradable ternary copolymer conjugated with folate as ligand, polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate (PEI-PCL-PEG-Fol) was synthesized and evaluated for targeted siRNA delivery via folate-FR recognition. The amphiphilic character of similar polymers was shown previously to support endosomal release of endocytosed nanocarriers and to promote formation of long circulating micelles. The obtained PEI-PCL-PEG-Fol exhibited less cytotoxicity in comparison with the corresponding ternary copolymer without folate (PEI-PCL-PEG) and with unmodified PEI25kDa. Stable micelle-like polyplexes with hydrodynamic diameters about 100 nm were found to have a zeta potential of +8.6 mV, which was lower than that of micelleplexes without folate-conjugation (+13-16 mV). Nonetheless, increased cellular uptake and in vitro gene knockdown of PEI-PCL-PEG-Fol/siRNA micelleplexes were observed in SKOV-3 cells, an FR overexpressing cell line, in comparison with the nonfolate-conjugated ones. Moreover, PEI-PCL-PEG-Fol/siRNA micelleplexes exhibited excellent stability in vivo during the analysis of 120 min and a longer circulation half life than hyPEI25kDa/siRNA polyplexes. Most interestingly, the targeted delivery system yielded 17% deposition of the i.v. injected siRNA per gram in the tumor after 24 h due to the effective folate targeting and the prolonged circulation.

Entities:  

Keywords:  SKOV-3 tumor xenograft; SPECT imaging; folate targeting; prolonged circulation; siRNA delivery; tumor targeting

Mesh:

Substances:

Year:  2015        PMID: 26641134     DOI: 10.1021/acs.molpharmaceut.5b00575

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  17 in total

1.  RGD-decorated cholesterol stabilized polyplexes for targeted siRNA delivery to glioblastoma cells.

Authors:  Bo Lou; Kate Connor; Kieron Sweeney; Ian S Miller; Alice O'Farrell; Eduardo Ruiz-Hernandez; David M Murray; Garry P Duffy; Alan Wolfe; Enrico Mastrobattista; Annette T Byrne; Wim E Hennink
Journal:  Drug Deliv Transl Res       Date:  2019-06       Impact factor: 4.617

Review 2.  Engineered Hydrogels for Local and Sustained Delivery of RNA-Interference Therapies.

Authors:  Leo L Wang; Jason A Burdick
Journal:  Adv Healthc Mater       Date:  2016-12-15       Impact factor: 9.933

Review 3.  Messenger RNA Delivery for Tissue Engineering and Regenerative Medicine Applications.

Authors:  Siddharth Patel; Avathamsa Athirasala; Paula P Menezes; N Ashwanikumar; Ting Zou; Gaurav Sahay; Luiz E Bertassoni
Journal:  Tissue Eng Part A       Date:  2018-06-07       Impact factor: 3.845

4.  Revisiting the value of competition assays in folate receptor-mediated drug delivery.

Authors:  Steven K Jones; Anwesha Sarkar; Daniel P Feldmann; Peter Hoffmann; Olivia M Merkel
Journal:  Biomaterials       Date:  2017-05-22       Impact factor: 12.479

5.  Impact of crystalline and amorphous matrices on successful spray drying of siRNA polyplexes for inhalation of nano-in-microparticles.

Authors:  Tobias Wm Keil; Christoph Zimmermann; Domizia Baldassi; Friederike Adams; Wolfgang Friess; Aditi Mehta; Olivia M Merkel
Journal:  Adv Ther (Weinh)       Date:  2021-05-07

6.  Correlating quantitative tumor accumulation and gene knockdown using SPECT/CT and bioluminescence imaging within an orthotopic ovarian cancer model.

Authors:  Steven K Jones; Kirk Douglas; Anthony F Shields; Olivia M Merkel
Journal:  Biomaterials       Date:  2018-06-13       Impact factor: 12.479

7.  Site-specific intestinal DMT1 silencing to mitigate iron absorption using pH-sensitive multi-compartmental nanoparticulate oral delivery system.

Authors:  Yingfang Fan; Harkiranpreet Kaur Dhaliwal; Archita Venugopal Menon; JuOae Chang; Jee Eun Choi; Mansoor M Amiji; Jonghan Kim
Journal:  Nanomedicine       Date:  2019-10-15       Impact factor: 5.307

8.  The impact of microfluidic mixing of triblock micelleplexes on in vitro / in vivo gene silencing and intracellular trafficking.

Authors:  Daniel P Feldmann; Yuran Xie; Steven K Jones; Dongyue Yu; Anna Moszczynska; Olivia M Merkel
Journal:  Nanotechnology       Date:  2017-05-10       Impact factor: 3.874

9.  Differential expression of folate receptor 1 in medulloblastoma and the correlation with clinicopathological characters and target therapeutic potential.

Authors:  Hailong Liu; Qianwen Sun; Mingshan Zhang; Zhihua Zhang; Xinyi Fan; Hongyu Yuan; Cheng Li; Yuduo Guo; Weihai Ning; Youliang Sun; Yongmei Song; Chunjiang Yu
Journal:  Oncotarget       Date:  2017-04-04

10.  In vitro and in vivo delivery of siRNA via VIPER polymer system to lung cells.

Authors:  Daniel P Feldmann; Yilong Cheng; Rima Kandil; Yuran Xie; Mariam Mohammadi; Hartmann Harz; Akhil Sharma; David J Peeler; Anna Moszczynska; Heinrich Leonhardt; Suzie H Pun; Olivia M Merkel
Journal:  J Control Release       Date:  2018-02-20       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.